AI assistant
Sending…
CLOROX CO /DE/ — Director's Dealing 2013
Nov 8, 2013
30403_dirs_2013-11-07_c21c16d7-1009-4e80-9698-34b862c63e02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2013-11-05
Reporting Person: Foster James E (SVP Chief Product Supply Off.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-05 | Common Stock | M | 20370.0000 | $57.2500 | Acquired | 33378.0000 | Direct |
| 2013-11-05 | Common Stock | M | 6220.0000 | $52.7000 | Acquired | 39598.0000 | Direct |
| 2013-11-05 | Common Stock | M | 4330.0000 | $57.0000 | Acquired | 43928.0000 | Direct |
| 2013-11-05 | Common Stock | S | 29625.0000 | $89.9977 | Disposed | 14303.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-05 | Stock Option (Right to Buy) | $57.2500 | M | 20370.0000 | Disposed | 2019-09-15 | Common Stock (20370.0000) | Direct |
| 2013-11-05 | Stock Option (Right to Buy) | $57.0000 | M | 4330.0000 | Disposed | 2015-09-21 | Common Stock (4330.0000) | Direct |
| 2013-11-05 | Stock Option (Right to Buy) | $52.7000 | M | 6220.0000 | Disposed | 2014-09-28 | Common Stock (6220.0000) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $89.96 to $90.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More from CLOROX CO /DE/
Regulatory Filings
2026
Jun 1
Board/Management Information
2026
May 28
Capital/Financing Update
2026
May 11
Regulatory Filings
2026
May 8
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29